Strategic Trastuzumab Mediated Crosslinking Driving Concomitant HER2 and HER3 Endocytosis and Degradation in Breast Cancer. (2020)

First Author: Wymant JM
Attributed to:  Optically-Guided Nanoparticles and Cell Scalextrics funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.7150/jca.32470

PubMed Identifier: 32231734

Publication URI: http://europepmc.org/abstract/MED/32231734

Type: Journal Article/Review

Volume: 11

Parent Publication: Journal of Cancer

Issue: 11

ISSN: 1837-9664